GBR or Autologous Bone Graft? Differences, Indications and Outcomes

Two roads for the same problem. Bone of insufficient volume and an implant that needs an adequate bony housing.

The first road is guided bone regeneration — GBR, for those who speak in acronyms. A membrane is placed over the defect, filled with a biomaterial (usually deproteinised bovine or porcine xenograft), and the body is left to do its work. No harvesting, no second surgical site.

The second road is the autologous bone graft. Bone is harvested from the chin, the mandibular ramus, or in the most extensive cases from the iliac crest. Living bone, with active osteogenic cells. The gold standard, the textbooks used to say.

And there is a third road: osteo-mucosal expansion, the one we Bonebenders love.

Same implants, different biological cost

The useful question is which road is right for that defect, in that patient.

Systematic reviews put implant survival close together. Aghaloo and Moy, across 2,620 implants in augmented ridges followed for 5 to 74 months, report 95.5% after GBR and 90.4% after onlay block grafts (Int J Oral Maxillofac Implants, 2007). Donos and colleagues set augmented sites against native bone within the same studies: 91.7-100% versus 93.2-100%, with follow-up between 12 and 59 months (J Clin Periodontol, 2008). Both roads reach almost the same final result. What changes is what they cost the patient, financially and biologically.

Autologous grafting imposes a second surgical field. That means more swelling, a risk of nerve injury at the donor site (the mental nerve, when harvesting from the chin, does not forgive easily), longer recovery. After an iliac crest harvest the patient walks poorly for weeks.

Pain depends heavily on where the bone comes from. Hartlev and colleagues recorded it hourly, then daily for a week, in 27 patients after a block harvest from the mandibular ramus, with a steroid on day one and analgesics for seven days (Int J Oral Maxillofac Surg, 2021). The mean peak, on a 0-100 scale, stayed between 13.6 and 21. An intraoral harvest, if well managed, hurts less than patients expect.

GBR avoids the second field. The trade-off is slightly longer healing — 6-9 months versus 4-6 — and membranes that sometimes become exposed. Calciolari, Donos and colleagues pooled the controlled studies comparing biomaterials for GBR performed with implant placement into a network meta-analysis (Periodontol 2000, 2023). When the biological principle of GBR is respected, bone regenerates predictably whatever the material. In large defects efficacy tends to drop, and part of the regenerated bone resorbs over time. Exposure, infection and dehiscence occur more often with cross-linked collagen membranes.

When autologous grafting is truly needed

In large three-dimensional defects. When centimetres are missing, not millimetres. After facial trauma, oncological resections, extreme atrophies that no biomaterial manages to fill alone.

But this scenario represents a minority of implant cases. Most bone defects encountered in practice — narrow ridges, post-extraction defects, fenestrations — are managed with GBR, with our osteo-mucosal expansion, or a combination of both. If you have been told you need bone from your hip, I have gathered the alternatives to hip harvesting.

The xenogeneic block and the uncertain data

Between GBR and autologous grafting sits a middle road. It is a pre-shaped block of animal bone instead of one harvested from the patient. Romito and colleagues tested it in 64 patients with ridges 4 mm wide or less, randomised to a collagenated equine block or an autologous block (J Clin Periodontol, 2022). At 30 weeks the width gained was 2.9 mm against 3.0 mm. Pain and analgesic use were lower in the xenogeneic group, especially in the first days. Early implant failure, however, was 20% against 10%.

The one-year follow-up confirms the trend (J Clin Periodontol, 2024): 78.6% survival in sites rebuilt with the xenogeneic block, 90.9% with autologous bone. The authors find no significant difference, but with 50 patients a twelve-point survival gap can stay below the statistical threshold. My reading: the xenogeneic block spares the patient pain, but has yet to show it works as well as autologous bone.

The third way. Our osteo-mucosal expansion

There is a technique often forgotten in this comparison. Osteo-mucosal expansion widens the existing bone from within instead of adding bone from outside. No harvesting, no biomaterial in many cases, rapid healing. The protocol is the Bruschi-Scipioni technique, published in 1994.

The meta-analysis of over 1,400 implants by Lin and colleagues reports 98.1% survival and 3.3 mm of ridge width gained. Those are the numbers behind the bonebending approach versus traditional GBR: the same result, with no bone to buy or harvest. This is the foundation of the customised regeneration approach used at Studio Denti Più.

How to choose

Anatomy makes the choice.

GBR when: the defect is contained (dehiscences, fenestrations, horizontal defects up to 5-6 mm), the patient prefers a less invasive procedure, healing time is not a concern.

Autologous graft when: the defect is large and three-dimensional, significant vital bone volume is required, local conditions (prior radiation, vascular compromise) demand living osteogenic cells.

Osteo-mucosal expansion when: the ridge is narrow but tall, the defect is predominantly horizontal, any harvesting or additional biomaterial is to be avoided.

In clinical reality, these techniques combine. Osteo-mucosal expansion with simultaneous GBR. A block graft with a covering membrane. The plan is drawn on that patient’s defect, not on the surgeon’s habit.

References

1. Donos N, Mardas N, Chadha V. Clinical outcomes of implants following lateral bone augmentation: systematic assessment of available options (barrier membranes, bone grafts, split osteotomy). J Clin Periodontol. 2008;35(8 Suppl):173-202. doi:10.1111/j.1600-051X.2008.01269.x · PMID: 18724850
2. Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70. PMID: 18437791
3. Jung RE, Fenner N, Hämmerle CH, et al. Long-term outcome of implants placed with guided bone regeneration (GBR) using resorbable and non-resorbable membranes after 12-14 years. Clin Oral Implants Res. 2013;24(10):1065-1073. doi:10.1111/j.1600-0501.2012.02522.x · PMID: 22697628
4. Calciolari E, Corbella S, Gkranias N, Viganó M, Sculean A, Donos N. Efficacy of biomaterials for lateral bone augmentation performed with guided bone regeneration. A network meta-analysis. Periodontol 2000. 2023;93(1):77-106. doi:10.1111/prd.12531 · PMID: 37752820
5. Romito GA, Villar CC, Sapata VM, Soares HH, Fonseca MA, Conde M, et al. Autogenous bone block versus collagenated xenogeneic bone block in the reconstruction of the atrophic alveolar ridge: a non-inferiority randomized clinical trial. J Clin Periodontol. 2022;49(11):1158-1168. doi:10.1111/jcpe.13701 · PMID: 35833539
6. Romito GA, Fonseca MA, Soares HH, de Oliveira Lazarin R, Sapata VM, Nishyama R, et al. Clinical outcomes following atrophic alveolar ridge reconstruction using collagenated xenogeneic bone block or autogenous bone block: one-year follow-up of a randomized controlled clinical. J Clin Periodontol. 2024;51(1):14-23. doi:10.1111/jcpe.13891 · PMID: 37846853
7. Hartlev J, Nørholt SE, Schou S, Isidor F. Pain after mandibular ramus block harvesting and lateral ridge augmentation with and without involvement of platelet-rich fibrin: a randomized controlled trial. Int J Oral Maxillofac Surg. 2021;50(3):384-390. doi:10.1016/j.ijom.2020.07.009 · PMID: 32798161

Insufficient bone for an implant? Read about customised bone regeneration or book a consultation with Dr. Bruschi.